Nuvei to Participate in Upcoming Investor Conferences
MONTREAL, May 27, 2021 (GLOBE NEWSWIRE) -- Nuvei Corporation ("Nuvei" or the "Company") (TSX: NVEI and NVEI.U), the global payment technology partner of thriving brands, today announced that the Company will be participating in the following virtual investor conferences:
William Blair 41st Annual Growth Stock Conference on Wednesday, June 2, 2021, at 3:40pm ET
Cowen 49th Annual Technology, Media & Telecom Conference on Thursday, June 3, 2021 at 3:50pm ET
BofA Securities 2021 Global Technology Conference on Tuesday, June 8, 2021, 11:30am ET
National Bank Financial 11th Annual Quebec Conference on Wednesday, June 16, 2021, at 10:00am ET
RBC Financial Technology Conference on Thursday, June 17, 2021, at 2:00pm ET
The Company's presentations will be available via live webcast and archived replay on Nuvei's investor relations website at https://investors.nuvei.com under the "Events & Presentations" section.
About Nuvei
We are Nuvei (TSX: NVEI and NVEI.U), the global payment technology partner of thriving brands. We provide the intelligence and technology businesses need to succeed locally and globally, through one integration ? propelling them further, faster. Uniting payment technology and consulting, we help businesses remove payment barriers, optimize operating costs and increase acceptance rates. Our proprietary platform connects merchants in 200 markets worldwide with local acquiring in 44 markets, supports 470 local and alternative payment methods, nearly 150 currencies and 40 cryptocurrencies. Our purpose is to make our world a local marketplace. For more information, visit www.nuvei.com.
Contact:
Investors Anthony Gerstein Vice President, Head of Investor Relations [email protected]
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024).
The campaign focuses on access to IBD care and treatment as the burden of...
The global industrial automation market in life sciences industry size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 11.4% during the forecast period. ...
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...
After tens of thousands of NYC children were turned away from "Summer Rising," New York City's popular, free summer enrichment program, Brains & Motion launched a campaign offering camps at NYU for a small fraction of the up-to-$1400 per week price...